H J Lerner

2.1k total citations · 1 hit paper
19 papers, 1.6k citations indexed

About

H J Lerner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, H J Lerner has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in H J Lerner's work include Cancer Treatment and Pharmacology (4 papers), Metastasis and carcinoma case studies (3 papers) and Colorectal Cancer Surgical Treatments (2 papers). H J Lerner is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Metastasis and carcinoma case studies (3 papers) and Colorectal Cancer Surgical Treatments (2 papers). H J Lerner collaborates with scholars based in United States. H J Lerner's co-authors include Carol Redmond, Norman Wolmark, Marvin J. Wexler, Edwin R. Fisher, Walter Lawrence, Judy Jones, B. Fisher, Howard E. Rockette, D. L. Wickerham and Anatolio B. Cruz and has published in prestigious journals such as Science, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

H J Lerner

19 papers receiving 1.5k citations

Hit Papers

Postoperative Adjuvant Chemotherapy or Radiation Therapy ... 1988 2026 2000 2013 1988 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H J Lerner United States 11 1.3k 763 531 280 88 19 1.6k
E. L. Bokey Australia 25 1.5k 1.1× 1.1k 1.5× 403 0.8× 300 1.1× 90 1.0× 50 1.9k
Frederick A. Coller United States 6 778 0.6× 535 0.7× 288 0.5× 319 1.1× 96 1.1× 11 1.2k
T Buroker United States 18 835 0.6× 603 0.8× 531 1.0× 170 0.6× 96 1.1× 21 1.4k
Harvey Brodovsky United States 17 476 0.4× 289 0.4× 252 0.5× 238 0.8× 78 0.9× 32 979
Andreas Marinelli Netherlands 21 1.1k 0.8× 914 1.2× 279 0.5× 82 0.3× 111 1.3× 47 1.5k
J. M. Skibber United States 14 1.2k 1.0× 691 0.9× 395 0.7× 176 0.6× 83 0.9× 38 1.6k
Diana Brinkley United Kingdom 21 434 0.3× 341 0.4× 325 0.6× 173 0.6× 410 4.7× 31 1.1k
B Unsgaard Sweden 15 408 0.3× 409 0.5× 261 0.5× 79 0.3× 70 0.8× 25 1.1k
Yeu‐Tsu N. Lee United States 16 614 0.5× 189 0.2× 341 0.6× 113 0.4× 177 2.0× 56 1.1k
Ho‐Kyung Chun South Korea 21 991 0.8× 597 0.8× 314 0.6× 219 0.8× 125 1.4× 44 1.3k

Countries citing papers authored by H J Lerner

Since Specialization
Citations

This map shows the geographic impact of H J Lerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H J Lerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H J Lerner more than expected).

Fields of papers citing papers by H J Lerner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H J Lerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H J Lerner. The network helps show where H J Lerner may publish in the future.

Co-authorship network of co-authors of H J Lerner

This figure shows the co-authorship network connecting the top 25 collaborators of H J Lerner. A scholar is included among the top collaborators of H J Lerner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H J Lerner. H J Lerner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Prager, David, Sharon Grundfest‐Broniatowski, H J Lerner, et al.. (1995). Breast cancer: are imaging studies cost effective following breast cancer and adjuvant therapy?. PubMed. 22(4). xiii, xix–xx, xxvi. 1 indexed citations
2.
Fisher, B., Norman Wolmark, Howard E. Rockette, et al.. (1988). Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011. JNCI Journal of the National Cancer Institute. 80(1). 21–29. 754 indexed citations breakdown →
3.
Wolmark, Norman, B. Fisher, Howard E. Rockette, et al.. (1988). Postoperative Adjuvant Chemotherapy or BCG for Colon Cancer: Results From NSABP Protocol C-011. JNCI Journal of the National Cancer Institute. 80(1). 30–36. 284 indexed citations
4.
Borden, Ernest C., David A. Amato, Charles Rosenbaum, et al.. (1987). Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.. Journal of Clinical Oncology. 5(6). 840–850. 237 indexed citations
5.
Lerner, H J, David A. Amato, Edwin D. Savlov, et al.. (1987). Eastern Cooperative Oncology Group: a comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma.. Journal of Clinical Oncology. 5(4). 613–617. 25 indexed citations
6.
Bonomi, Philip, et al.. (1984). Doxorubicin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.. PubMed. 68(9). 1163–5. 11 indexed citations
7.
Lerner, H J, et al.. (1983). Gastric cancer‐survival at the pennsylvania hospital with and without adjuvant chemotherapy. Journal of Surgical Oncology. 23(3). 201–204. 1 indexed citations
8.
Lerner, H J, et al.. (1983). Second malignancies diagnosed in patients receiving chemotherapy at the pennsylvania hospital. Journal of Surgical Oncology. 23(3). 195–197. 2 indexed citations
9.
Vogl, Steven E., et al.. (1982). Chemotherapy for inoperable, non-small cell bronchogenic carcinoma: EST 2575, generation II.. PubMed. 65(11-12). 965–72. 16 indexed citations
10.
Fisher, Bernard, Carol Redmond, Elias Eg, et al.. (1982). Adjuvant chemotherapy for breast cancer: an overview of NSABP findings.. PubMed. 5. 65–90. 6 indexed citations
11.
Metz, Henry S & H J Lerner. (1981). The Adjustable Harada-Ito Procedure. Archives of Ophthalmology. 99(4). 624–626. 53 indexed citations
12.
Glass, Andrew G., Wieand Hs, Bernard Fisher, et al.. (1981). Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents.. PubMed. 65(5-6). 363–76. 28 indexed citations
13.
Creech, Richard H., Cyrus R. Mehta, Robert W. Sponzo, et al.. (1981). Results of a phase II protocol for evaluation of new chemotherapeutic regimens in patients with inoperable non-small cell lung carcinoma (EST-2575, generation I).. PubMed. 65(5-6). 431–8. 15 indexed citations
14.
Vogl, Steven E., et al.. (1980). Head and neck cancer chemo therapy with di ammine di chloro platinum bleomycin methotrexate and mitomycin. 21. 478. 1 indexed citations
15.
Lerner, H J, Pierre R. Band, L Israël, & Benjamin S. Leung. (1976). Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(10). 1431–5. 90 indexed citations
16.
Lerner, H J, et al.. (1967). Combined chemotherapy and radiotherapy. Preliminary results of clinical trial of hydroxyurea and x-irradiation in the treatment of epidermoid cancers of the head and neck.. PubMed. 33(3). 165–70. 9 indexed citations
17.
Sulzberger, Marion B., Austin H. Kutscher, & H J Lerner. (1966). Dimethyl Sulfoxide Conference. Science. 153(3736). 576–576. 2 indexed citations
18.
Lerner, H J, et al.. (1965). Hydroxyurea (NSC-32065) in biologic fluids: dose-concentration relationship.. PubMed. 48. 57–8. 43 indexed citations
19.
Lerner, H J, et al.. (1963). Heparin Suppression of Gastric Acid Secretion.. Experimental Biology and Medicine. 112(3). 730–732. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026